Advertisement
For adults hospitalized with COVID-19 with lower respiratory tract infection

Remdesivir Beats Placebo for Time to COVID-19 Recovery

0
Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
The World Health Organization has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.

WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients

0
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
Reacting to skyrocketing prices for insulin

New Medicare Benefit Would Limit Insulin Copays to $35 a Month

0
Benefit will be voluntary; Medicare recipients must pick an insurance plan that provides it
Primary aldosteronism is prevalent and increases in parallel with hypertension severity

High Prevalence of Primary Aldosteronism Observed

0
Adjusted prevalence estimates of aldosteronism increase in parallel with hypertension severity
Use of biomechanical footwear is associated with an improvement in pain among patients with knee osteoarthritis at 24 weeks of follow-up

Biomechanical Footwear May Aid Knee Osteoarthritis Outcomes

0
While significant improvement seen across pain, function, stiffness scores, clinical impact remains uncertain
A chest X-ray severity score can predict outcomes among young and middle-aged adults with COVID-19 on presentation to the emergency department

ED Chest X-Ray Score Predicts COVID-19 Outcomes in Adults <50

0
CXR severity score ≥2 and obesity independent predictors of hospital admission
Children may experience acute cardiac decompensation due to a severe inflammatory state (multisystem inflammatory syndrome in children) following infection with severe acute respiratory syndrome coronavirus 2

Cardiac Decompensation Seen in Children Following COVID-19

0
Cardiac decompensation occurred in conjunction with multisystem inflammatory syndrome in some children
In Northern California

Incidence of AMI Hospitalization Down During COVID-19

0
Decrease seen in incidence of STEMI, NSTEMI in Northern California during COVID-19 period versus pre-COVID-19
The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford

U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research

0
Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
Older age

Age, Sex, History of Diabetes Predict Intubation in COVID-19

0
Only factors independently associated with time to extubation are age and body mass index